Evidence Watch
Ayurveda for diabetes: what the trials actually show
A substantial number of trials have examined Ayurvedic preparations in type 2 diabetes. The findings are worth knowing, and so is the reason none of them should change your treatment.

Type 2 diabetes is common in India and elsewhere in South Asia, Ayurvedic preparations are widely used for it, and there is a corresponding research literature.
This article summarises it and states clearly, at the outset, that nothing here is a reason to alter prescribed treatment.
The preparations most studied
Gymnema sylvestre. Traditional use is long-standing, and the plant has the interesting property of temporarily suppressing sweet taste perception. Clinical trials exist, generally small, with some reporting reductions in glycaemic measures. Reviews have described the evidence as insufficient in quality to draw firm conclusions.
Fenugreek. Several trials and some meta-analyses report reductions in fasting glucose and HbA1c. The soluble fibre content provides a plausible mechanism. Effect sizes vary and study quality is generally limited.
Bitter melon. Extensively used traditionally. Trials have produced inconsistent results, and reviews have generally concluded that evidence is insufficient. Some studies have found no significant effect compared with placebo.
Cinnamon. Widely marketed. Meta-analyses have produced conflicting conclusions, with some finding modest reductions in fasting glucose and others not. Heterogeneity between studies is substantial, and the species used differs between trials, which matters.
Salacia and other preparations, with smaller literatures.
Multi-herb formulations, which are what practitioners typically prescribe. These are harder to study, since the composition varies and attributing any effect to a component is impossible.
The pattern across the literature
Small trials. Short duration, frequently twelve weeks or less. Heterogeneous preparations and doses. Variable outcome measures. Limited independent replication. Frequent methodological weaknesses including inadequate blinding and unclear randomisation.
Reviews of this literature — including reviews conducted by researchers sympathetic to traditional medicine — have consistently identified these limitations and called for larger, better-designed trials.
Where effects are reported, they are generally modest reductions in fasting glucose or HbA1c, of a magnitude smaller than established pharmaceutical treatment produces.
Why this matters more here than in most areas
Diabetes is a condition where inadequate control produces cumulative and largely irreversible harm.
Retinopathy leading to blindness. Nephropathy leading to kidney failure. Neuropathy, foot ulceration and amputation. Substantially elevated cardiovascular risk.
These develop silently over years. Someone whose control deteriorates does not feel it happening, and the damage accrued cannot be undone by improving control later.
Which means the cost of substituting an inadequately evidenced treatment for an effective one is not a wasted opportunity. It is measurable organ damage.
The specific dangers
Stopping prescribed medication. The most serious risk. Cases of severe hyperglycaemia and diabetic ketoacidosis following discontinuation of prescribed treatment in favour of alternative therapies are documented.
Additive hypoglycaemia. If a preparation does lower glucose, taking it alongside medication that also does can produce hypoglycaemia, which is dangerous. This is a reason to tell your doctor about supplements, not a reason to keep them secret.
Adulteration with pharmaceuticals. This is a documented and serious problem. Herbal antidiabetic products in several countries have been found adulterated with undeclared pharmaceutical glucose-lowering agents, including drugs that have been withdrawn from markets for safety reasons.
Someone taking such a product alongside their prescribed medication is taking an unknown dose of an undeclared drug, which has caused serious hypoglycaemia.
Heavy metal contamination, discussed elsewhere on this site, and a particular concern for someone with diabetes given the kidney implications.
What does have strong evidence
It is worth stating clearly, because it is where the actual benefit lies.
Weight loss, where achieved, has substantial evidence including for remission of type 2 diabetes in a proportion of people. Structured programmes achieving significant weight loss have produced remission in a meaningful share of participants in controlled trials.
Physical activity, with good evidence for glycaemic control and cardiovascular risk.
Dietary change — reduced refined carbohydrate, increased fibre and vegetables, and appropriate energy intake.
Established pharmaceutical treatment, with extensive outcome data including on the complications that matter.
Blood pressure and lipid management, which affect the outcomes as much as glucose control does.
Smoking cessation.
How to combine approaches sensibly
Continue prescribed treatment. Attend monitoring appointments. Tell your doctor about every supplement you take, including Ayurvedic preparations, with the ingredient list.
Dietary and lifestyle advice from an Ayurvedic practitioner that overlaps with mainstream advice — regular meals, more vegetables, activity, weight management — is compatible and may be more culturally acceptable and better followed, which has genuine value.
Any practitioner who advises stopping or reducing prescribed diabetes medication without involving the prescribing doctor should not be treating you.
Do not stop or reduce prescribed diabetes medication. Tell your doctor about any supplement you take. Symptoms of very high or very low blood glucose require urgent attention.
Also by Sanjay Iyer
- The placebo question, taken seriouslyEvidence Watch
- Diuretic herbs and the kidneyHerbs & Formulations
- Yoga injuries and how to practise without acquiring oneYoga & Breath
- Arjuna and the heart claimsHerbs & Formulations





